CG · Carlyle Group Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.00M | - | $332.70M | $1.57B | $973.10M | - | $2.64B | $1.07B | $688.40M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $368.60M | - | $370.10M | $1.18B | $808.20M | - | $1.85B | $845.80M | $560.70M | - |
| D&A | $50.50M | - | - | - | $46.90M | - | - | - | $45.30M | - |
| Operating Income | ($179.00M) | - | $85.80M | $440.60M | $171.00M | - | $788.80M | $218.80M | $120.70M | - |
| Interest Expense | $38.60M | - | $29.80M | $28.00M | $27.80M | - | $30.30M | $30.40M | $30.80M | - |
| Income Tax | ($37.10M) | - | ($26.70M) | $112.50M | $12.40M | - | $173.10M | $69.50M | $21.90M | - |
| Net Income | ($132.20M) | - | $900.0K | $319.70M | $130.00M | - | $595.70M | $148.20M | $65.60M | - |
| EPS - Basic | ($0.37) | - | $0.00 | $0.89 | $0.36 | - | $1.67 | $0.41 | $0.18 | - |
| EPS - Diluted | ($0.37) | - | $0.00 | $0.87 | $0.35 | - | $1.63 | $0.40 | $0.18 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.67B | $1.97B | $2.22B | $1.28B | $1.19B | $1.27B | $1.38B | $914.80M | $1.28B | $1.44B |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $29.84B | $29.12B | $27.06B | $25.07B | $24.10B | $23.10B | $22.66B | $22.28B | $20.85B | $21.18B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $22.47B | $22.06B | $20.21B | $18.35B | $17.71B | $16.76B | $16.32B | $16.55B | $15.11B | $15.39B |
| Stockholders' Equity | $7.37B | $7.06B | $6.85B | $6.72B | $6.39B | $6.35B | $6.34B | $5.73B | $5.74B | $5.78B |
| Retained Earnings | $1.17B | $1.64B | $1.62B | $1.95B | $1.86B | $2.04B | $2.03B | $1.71B | $1.87B | $2.08B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($1.24B) | - | - | - | ($352.10M) | - | - | - | $71.10M | - |
| Investing Cash Flow | ($28.10M) | - | - | - | ($16.70M) | - | - | - | ($14.20M) | - |
| Financing Cash Flow | $988.30M | - | - | - | $296.60M | - | - | - | ($216.70M) | - |
| CapEx | $28.10M | - | - | - | $16.70M | - | - | - | $14.20M | - |
| Free Cash Flow | ($1.27B) | - | - | - | ($368.80M) | - | - | - | $56.90M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -70.5% | - | 25.8% | 28.0% | 17.6% | - | 29.9% | 20.5% | 17.5% | - |
| EBITDA margin | -50.6% | - | - | - | 22.4% | - | - | - | 24.1% | - |
| Net margin | -52.0% | - | 0.3% | 20.3% | 13.4% | - | 22.6% | 13.9% | 9.5% | - |
| Free cash flow margin | -500.2% | - | - | - | -37.9% | - | - | - | 8.3% | - |
| FCF / Net income | 9.61 | - | - | - | -2.84 | - | - | - | 0.87 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | 26.0% | 8.7% | - | 22.5% | 31.9% | 25.0% | - |
| Return on assets | -0.4% | - | 0.0% | 1.3% | 0.5% | - | 2.6% | 0.7% | 0.3% | - |
| Return on equity | -1.8% | - | 0.0% | 4.8% | 2.0% | - | 9.4% | 2.6% | 1.1% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -4.6x | - | 2.9x | 15.7x | 6.2x | - | 26.0x | 7.2x | 3.9x | - |
| Equity multiplier | 4.05 | 4.13 | 3.95 | 3.73 | 3.77 | 3.64 | 3.58 | 3.89 | 3.63 | 3.66 |
| Liabilities / Assets | 0.75 | 0.76 | 0.75 | 0.73 | 0.74 | 0.73 | 0.72 | 0.74 | 0.72 | 0.73 |
| Efficiency | ||||||||||
| Asset turnover | 0.01 | - | 0.01 | 0.06 | 0.04 | - | 0.12 | 0.05 | 0.03 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | 59.1x | 124.5x | - | 26.4x | 100.4x | 260.6x | - |
| P / B | 2.4x | - | 3.4x | 2.8x | 2.5x | - | 2.5x | 2.6x | 3.0x | - |
| P / S | 68.4x | - | 71.0x | 12.0x | 16.4x | - | 6.0x | 13.8x | 25.2x | - |
| EV / EBITDA | - | - | - | - | 67.8x | - | - | - | 96.7x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -73.9% | - | -87.4% | 47.0% | 41.4% | - | 267.7% | 131.5% | -19.9% | - |
| Revenue CAGR (3y) | -33.4% | - | -32.6% | 14.5% | -15.0% | - | 17.1% | -26.6% | -34.4% | - |
| Revenue CAGR (5y) | -36.4% | - | -20.3% | 6.8% | - | - | 27.9% | 0.2% | -8.7% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | -89.1% | 101.4% | 41.7% | - | 418.3% | - | -24.4% | - |
| Net income growth (YoY) | - | - | -99.8% | 115.7% | 98.2% | - | 632.7% | - | -34.9% | - |
| EPS growth (YoY) | - | - | - | 117.5% | 94.4% | - | 640.9% | - | -35.7% | - |
| EPS CAGR (3y) | - | - | - | 9.1% | -39.4% | - | 3.7% | -46.1% | -57.9% | - |
| EPS CAGR (5y) | - | - | - | 16.2% | - | - | 24.3% | -20.1% | -31.3% | - |
| FCF growth (YoY) | -244.5% | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 15.5% | 11.2% | 8.0% | 17.2% | 11.2% | 9.7% | -2.6% | -13.8% | -15.7% | -15.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$5.29B totalGlobal Segments$2.64B · 50.0%
Global Private Equity Segment$1.22B · 23.0%
Global Credit Segment$910.10M · 17.2%
Carlyle Alp Invest Segment$517.00M · 9.8%
Product / service
$2.63B totalFund Management Fee$2.40B · 91.3%
Incentive Fee$190.50M · 7.3%
Investment Advice$39.00M · 1.5%
Fee Related Performance Revenues$300.0K · 0.0%
Geographic
$4.78B totalAmericas$3.28B · 68.7%
EMEA$1.45B · 30.4%
Asia Pacific$46.60M · 1.0%
Peer comparison
Same SIC group: Investment Advice
Comparing Carlyle Group Inc. against the 5 most active filers in the same SIC group.
Dividends
$1.40/share trailing 12 months · 0.0% YoY
| Ex-date | Per share |
|---|---|
| May 18, 2026 | $0.3500 |
| Feb 13, 2026 | $0.3500 |
| Nov 10, 2025 | $0.3500 |
| Aug 18, 2025 | $0.3500 |
| May 19, 2025 | $0.3500 |
| Feb 21, 2025 | $0.3500 |
| Nov 18, 2024 | $0.3500 |
| Aug 16, 2024 | $0.3500 |
| May 13, 2024 | $0.3500 |
| Feb 22, 2024 | $0.3500 |
| Nov 20, 2023 | $0.3500 |
| Aug 14, 2023 | $0.3500 |
| May 15, 2023 | $0.3500 |
| Feb 21, 2023 | $0.3250 |
| Nov 17, 2022 | $0.3250 |
| Aug 8, 2022 | $0.3250 |
| May 9, 2022 | $0.3250 |
| Feb 14, 2022 | $0.2500 |
| Nov 8, 2021 | $0.2500 |
| Aug 9, 2021 | $0.2500 |
| May 10, 2021 | $0.2500 |
| Feb 12, 2021 | $0.2500 |
| Nov 9, 2020 | $0.2500 |
| Aug 10, 2020 | $0.2500 |